Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Shares Outstanding (Diluted Average): 2010-2024

Historic Shares Outstanding (Diluted Average) for Myriad Genetics (MYGN) over the last 9 years, with Dec 2024 value amounting to $90.6 million.

  • Myriad Genetics' Shares Outstanding (Diluted Average) rose 2.42% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year increase of 2.42%. This contributed to the annual value of $90.6 million for FY2024, which is 9.42% up from last year.
  • Per Myriad Genetics' latest filing, its Shares Outstanding (Diluted Average) stood at $90.6 million for FY2024, which was up 9.42% from $82.8 million recorded in FY2023.
  • In the past 5 years, Myriad Genetics' Shares Outstanding (Diluted Average) ranged from a high of $90.6 million in FY2024 and a low of $74.3 million during FY2020.
  • For the 3-year period, Myriad Genetics' Shares Outstanding (Diluted Average) averaged around $84.7 million, with its median value being $82.8 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first fell by 2.24% in 2020, then rose by 9.42% in 2024.
  • Yearly analysis of 5 years shows Myriad Genetics' Shares Outstanding (Diluted Average) stood at $74.3 million in 2020, then reached $75.0 million in 2020, then rose by 4.00% to $78.0 million in 2021, then increased by 3.33% to $80.6 million in 2022, then rose by 2.73% to $82.8 million in 2023, then rose by 9.42% to $90.6 million in 2024.